We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Deep Learning–Based Method Improves Cancer Diagnosis

By LabMedica International staff writers
Posted on 12 Jan 2026

Identifying vascular invasion is critical for determining how aggressive a cancer is, yet doing so reliably can be difficult using standard pathology workflows. More...

Conventional methods require multiple chemical stains to be applied to separate tissue sections, which increases cost, processing time, and the risk of losing diagnostic information. Researchers have now developed an artificial intelligence (AI)-based approach that can digitally generate multiple diagnostic stains from a single unstained tissue section, enabling more accurate assessment of cancer invasion.

Researchers at the University of California, Los Angeles (UCLA, Los Angeles, CA, USA), in collaboration with Hadassah Hebrew University Medical Center (Jerusalem, Israel) and the University of Southern California (USC, Los Angeles, CA, USA), have introduced a virtual multiplexed immunohistochemistry framework that converts autofluorescence microscopy images of label-free tissue into brightfield-equivalent images of hematoxylin and eosin staining, along with two key immunohistochemical markers: ERG for endothelial cells and PanCK for epithelial tumor cells.

Unstained tissue sections were first imaged using autofluorescence microscopy. A conditional generative adversarial network then digitally transformed these images into multiple virtual stains using a single deep neural network. A digital staining matrix guided the model to produce precisely aligned virtual H&E, ERG, and PanCK images from the same tissue section, eliminating the need for serial sectioning and chemical staining.

When applied to thyroid tissue microarrays, the virtual staining approach showed high concordance with conventional histochemical and immunohistochemical stains. In blinded evaluations, board-certified pathologists found that the digitally generated stains were comparable to traditional methods and, in some cases, demonstrated improved consistency and specificity. The approach, presented in BME Frontiers, enabled clearer visualization of tumor cells within blood or lymphatic vessels, supporting more reliable identification of vascular invasion.

Because the staining is generated computationally, the method avoids many artifacts associated with conventional immunohistochemistry and delivers highly reproducible results. Virtual stains can be produced within seconds for individual regions and in minutes for whole-slide images, making the framework compatible with high-throughput digital pathology workflows. While demonstrated in thyroid cancer, the approach could be extended to other tumor types and additional diagnostic markers, pending further multi-center clinical validation.

Related Links:
UCLA
Hadassah Hebrew University Medical Center
USC


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.